1Spatial Plc - Interim Results
1Spatial plc (AIM: SPA)
("1Spatial", the "Group" or the "Company")
Interim Results for the six-month period ended
Stronger recurring revenue mix and ongoing strategic delivery
1Spatial, (AIM: SPA), a global leader in Location Master Data Management (LMDM) software and solutions, is pleased to announce interim results for the six months ended
H1 2026 highlights
|
· |
Revenue up 9% to |
|
|
|
o |
20% increase in recurring revenue to |
|
|
o |
50% increase in SaaS and Term Licences revenues, with fourfold growth in 1Streetworks revenues to |
|
· |
Annualised Recurring Revenue (ARR) growth of 11% to |
|
|
· |
Adjusted EBITDA margin tempered 0.4pps to 11.9% reflecting the H1 revenue mix (H1 2025: 12.3%) |
|
|
· |
Net borrowings increased to |
|
|
· |
Signed strategically important multi-year licence deals with existing clients including |
|
|
· |
Post period end, signed a |
|
|
· |
H2 weighting of renewals and a healthy pipeline provide the Board with confidence in achieving results for FY26 in line with management expectations |
|
Financial highlights
|
|
Half-year to |
Half-year to |
|
|
|
Change |
||
|
|
|
||
|
|
£m |
£m |
% |
|
|
|
|
|
|
Group revenue |
17.7 |
16.2 |
+9 |
|
Recurring revenue |
10.7 |
8.9 |
+20 |
|
This includes: |
|
|
|
|
Term licences revenue |
5.6 |
4.1 |
+37 |
|
SaaS solutions revenue |
0.8 |
0.2 |
+300 |
|
|
|
|
|
|
Group Total ARR |
19.9 |
17.9 |
+11 |
|
Term licences ARR |
9.3 |
8.2 |
+13 |
|
SaaS ARR |
1.8 |
0.3 |
+500 |
|
|
|
|
|
|
Group gross profit |
8.8 |
8.5 |
+4 |
|
Group gross profit margin (%) |
49.7 |
52.2 |
-2.5pp |
|
Adjusted EBITDA |
2.1 |
2.0 |
+5 |
|
Adjusted EBITDA margin (%) |
11.9 |
12.3 |
-0.4pp |
|
Operating profit |
0.0 |
0.1 |
- |
|
Loss before tax |
(0.3) |
(0.2) |
-94 |
|
Loss per share - basic and diluted (p) |
(0.3) |
(0.2) |
-50 |
|
Net borrowings |
(2.5) |
(0.9) |
-178 |
Outlook
|
· |
The second half has started well, with several contract renewals and notable expansions in the |
|
· |
The Company has a robust order book and several ongoing European programmes which underpin the H2 weighted profile and provide the Board with confidence in achieving management expectations for the full year. |
Commenting on the results, 1Spatial CEO,
"We have delivered a positive first half, despite challenging global market conditions. We have focused on the successful execution of our strategic priorities, expanding our engagements with existing customers and securing some good wins towards the end of the half and into Q3.
"As we look ahead, our focus remains on accelerating SaaS adoption, converting our robust pipeline and deepening our presence in the substantial US market. We are confident the strength of our IP, breadth of customer base and expertise across our team mean we are well placed to deliver attractive growth and cash generation over the medium term."
For further information, please contact:
|
1Spatial plc |
01223 420 414 |
|
|
|
|
Panmure Liberum (Nomad and Broker) |
020 3100 2000 |
|
|
|
|
Cavendish (Joint Broker) |
020 7220 0500 |
|
|
|
|
Alma Strategic Communications |
020 3405 0205 |
|
|
Alternative Performance Measures ('APMs')
The Group uses certain Alternative Performance Measures to enable the users of the Group's financial statements to understand and evaluate the performance of the Group consistently over different reporting periods. APMs are non-GAAP company specific measures. As these are non-GAAP measures, they should not be considered as replacements for IFRS measures. The Group's definition of non-GAAP measures may not be comparable to other similarly titled measures reported by other companies. A description of the measures set out above is included below with a reconciliation to the closest GAAP measure included in the notes to the consolidated condensed interim financial report.
|
APM |
Explanation of APM |
|
Recurring Revenue (s)
|
Recurring Revenue is the value of committed recurring contracts for term licences and support & maintenance recorded in the year. |
|
Annualised Recurring Revenue ("ARR") |
Annualised Recurring Revenue ("ARR") is the annualised value at the year-end of committed recurring contracts for term licences and support & maintenance. |
|
Adjusted EBITDA
|
Adjusted EBITDA is a company-specific measure which is calculated as operating profit/(loss) before depreciation (including right of use asset depreciation), amortisation and impairment of intangible assets, share-based payment charge and strategic, integration, and other non-recurring items. |
|
Operating cashflow |
Operating cashflow is a company-specific measure which is calculated as cash generated from operations excluding cash flow on strategic, integration and other non-recurring items. |
|
Free cashflow |
Free cash flow is defined as net increase/(decrease) in cash for the year before cash flows from the acquisition of subsidiaries, cash flows from new borrowings and repayments of borrowings and cash flow from new share issue. But excludes lease liabilities. |
|
Net cash/(borrowings) |
Net cash/(borrowings) is gross cash less bank borrowings. |
About 1Spatial plc
1Spatial is a global leader in Location Master Data Management ('LMDM') software and solutions. Our global clients include national mapping and land management agencies, utility companies, transportation organisations, government, public safety and defence departments.
Our user-friendly, no-code, cloud-enabled solutions and business applications facilitate automated data governance, while delivering increased efficiencies and significant cost-savings - contributing to a safer, smarter and more sustainable world.
Our patented rules engine powers a cutting-edge software platform, as well as a suite of proprietary business applications and SaaS products, including 1Streetworks which revolutionises traffic management in the
1Spatial plc is AIM quoted, with operations in the
Half-year review
We are pleased to report a positive first-half performance despite challenging trading conditions in certain markets which has caused delays in contract signings. Revenues were up 9% to
Key renewal and expansion contracts secured during the period included a four-year expanded renewal with the
Post period end, on 30 September we entered into an expanded
On 3 October, 1Spatial was awarded a
These contracts announced post period end provide a good underpin for revenue progression in H2 FY26 and FY27 and beyond.
We remain focused on expanding our US operations and SaaS businesses, particularly 1Streetworks, by leveraging the strength of our established Enterprise business. The targeted investments in sales and marketing capacity in FY25 have delivered an increase in pipeline, which we are focused on converting. The Board is currently considering its strategic options for its Australian business. If value was realised, it would allow accelerated investment into our next generation data platform and SaaS products which would accelerate the development of these key growth drivers.
1Streetworks
The first half of FY26 saw steady progress for our innovative SaaS-based 1Streetworks offering, with revenue increasing to
The market opportunity remains substantial at
The
Our commercial sales model is now more established, beginning with paid trials that lead to regional or divisional rollouts and subsequent scaling. The pipeline for 1Streetworks has increased in value by 60% since January. As the solution becomes increasingly validated the sales cycle should shorten with growing industry awareness aiding adoption.
With 1Streetworks now firmly case-proven, we intend to further invest in sales resources, to accelerate market penetration.
Ongoing enhancement of the platform remains a strategic priority, focused on expanding use cases, broadening market applicability, and supporting scalable commercial models.
Enterprise business expansion
Our Enterprise business, which comprises revenues from geospatial software and services across our key regions of
Despite the slower pace of decision making in the US, we have been able to grow our ARR levels by 5%. In June we were pleased to sign a four-year contract renewal valued at
The
Caltrans is one of the most influential Departments of Transport (DOT) in the US and use cases that have been implemented within
We continued to build our seven enterprise Next Generation 9-1-1 (NG9-1-1) enterprise accounts, including renewals in
1Spatial
During the period, we renewed several third-party software licences. One of these was with Defra for a software licence centred on FME technology. The Defra account is important to us, serving as the lead engagement across the wider Defra group, which includes the Environment Agency, Rural Payments Agency, and the Animal and Plant Health Agency. We also renewed with Network Rail delivered through VertiGIS technology, supporting their digital transformation and asset management programmes. These third-party strategic renewals reinforce our position as a trusted advisor and enable us to maintain and expand our footprint across central government and infrastructure sectors.
We continue to advance our strategic project with QinetiQ and a major UK Government agency, combining service delivery with the development of our aeronautical technology. Originally scheduled for completion in 2024, the programme remains in progress, with full deployment now expected in Q2 FY27. Upon completion, the project is anticipated to contribute
The
We have increased our ARR in
Our flagship project with a leading utility distribution system operator (DSO) in
As of
During the period, Annual Recurring Revenue (ARR) increased by 31% year-on-year, supported by new licence agreements and renewals with key organisations including the Department of Energy, Environment and Climate Action, the Department of Transport and Planning, Geoscience Australia, and Endeavour Energy.
Total revenue in
The region maintains a healthy pipeline of opportunities across both software and services.
R&D, Innovation and AI strategy
During the period, we continued to invest in our core technology portfolio, including the 1Spatial Location Master Data Management (LMDM) platform, sector-specific applications for Water, Telecoms, and Local Government in
We also initiated a review of our LMDM platform to align with industry best practice and integrate emerging AI capabilities. With over 30 years of expertise in managing complex, location-centric data, 1Spatial is well positioned to capitalise on the growing demand for validated, structured data in AI-driven environments. Our next-generation platform will be designed to accelerate specification development, rule creation, and corrective actions which will enhance time-to-value and ROI for customers, while increasing partner-led scalability. We are now working with key customers and partners on proof-of-concept deployments of our AI-enabled platform.
Development of our aeronautical products is expected to complete by Spring 2026, with associated investment redirected to support the next-generation platform roadmap.
Current trading and outlook
The second half of the year has started well, despite a challenging market environment, with major contract renewals secured in both
The Board remains confident in delivering further progress in FY26, maintaining discipline on costs and cash conversion while continuing to selectively invest in the growth of 1Streetworks, our US go-to-market strategy and the next generation of our industry leading platform.
Chief Executive Officer
Financial performance
Summary
The Group delivered a satisfactory financial performance during the period, marked by continued growth in recurring revenues and a further shift towards subscription-based income streams. Enhanced sales capabilities and a focus on higher-quality contracts contributed to increased revenues, while cost management remained disciplined. The business continues to invest in its sales resources to secure long-term, high-value contracts and drive sustained pipeline growth.
Revenue
Group revenue grew by 9% to
|
Revenue by type |
|
|
|
|
|
H1 2026 |
H1 2025 |
% change |
|
Recurring revenue (term licences, SaaS + S&M) |
10.70 |
8.91 |
20% |
|
Services |
6.81 |
6.85 |
(1%) |
|
Revenue (excluding perpetual licences) |
17.51 |
15.76 |
11% |
|
Perpetual licences |
0.14 |
0.48 |
(71%) |
|
Total revenue |
17.65 |
16.24 |
9% |
Growth in term licence and SaaS ARR
We drive growth across our portfolio through continued expansion in term licence sales and the conversion of our significant SaaS pipeline. In the twelve months to 31 July 2025, the annualised value of term licences and SaaS solutions grew by 31%, with SaaS delivering exceptional growth of 604%.
|
|
H1 2026 |
H1 2025 |
Growth |
|
ARR for term licences |
9.34 |
8.24 |
13% |
|
ARR for SaaS solutions |
1.76 |
0.25 |
604% |
|
ARR for licences - total |
11.10 |
8.49 |
31% |
Annualised Recurring Revenue
Annualised Recurring Revenue (ARR) grew by 11%, from £17.92m at 31 July 2024 to £19.87m at 31 July 2025. Growth rates varied by region, with
|
ARR by region |
|
|
|
|
|
H1 2026 |
H1 2025 |
Growth |
|
|
7.82 |
7.07 |
11% |
|
|
6.27 |
5.80 |
7% |
|
US |
3.36 |
3.21 |
5% |
|
|
2.42 |
1.84 |
31% |
|
Total ARR |
19.87 |
17.92 |
11% |
Committed services revenue
Committed services revenue decreased by 22%, from £14.5m to £11.3m in H1 2026, reflecting the planned delivery of significant contracts previously secured in
The combination of growing ARR, a healthy backlog of committed services revenue, and a strong pipeline of opportunities positions the business well to achieve its revenue growth objectives. The Company's strategic focus on developing and selling repeatable software solutions enables the Board to invest with confidence.
Regional revenue
Revenue by region is shown in the table below:
|
Regional revenue |
|
|
|
|
|
|
H1 2026 |
H1 2025 |
Growth % |
|
|
|
7.25 |
5.86 |
23% |
|
|
|
5.80 |
5.69 |
2% |
|
|
US |
2.61 |
2.53 |
4% |
|
|
|
1.99 |
2.16 |
(9%) |
|
|
|
17.65 |
16.24 |
9% |
|
We are pleased to report a 9% increase in revenue driven primarily by double-digit growth in the UK&I following significant contract wins and expansions. While the
Gross profit margin
Gross profit for the period increased by 4% to £8.8m (H1 FY25: £8.5m). As a result of a higher proportion of lower-margin third-party term licence sales with certain strategically important government customers in H1, the gross profit margin reduced to 49.7% (HY25: 52.2%). While the business is making planned investments to support future revenue growth, the management team continue to focus on driving improvements to gross margin levels through sale of higher-margin proprietary term licences and SaaS products.
Adjusted EBITDA
Adjusted EBITDA increased slightly to approximately £2.1m, with EBITDA margin slightly lower year‑on‑year. Targeted investment in people remains critical to deliver strategic sales, and we will continue to invest. We expect a stronger second half, reflecting the typical weighting of term licence renewals and increased revenue from major European programmes, with our sales teams well positioned to drive term licence and SaaS growth.
Operating profit
The Group recorded an operating result of £0.0m, broadly in line with the previous year.
Taxation
The tax charge for the period was £0.1m (H1 2025: £0.1m).
Balance sheet
The Group's net assets increased to £18.4m at 31 July 2025 (H1 2025: £18.2m). The primary driver of this increase was a rise in intangible assets to £22.5m (H1 2025: £20.5m) offset by the increase in bank borrowings to £5.9m (H1 2025: £3.6m).
The increase in the net intangible asset balance is primarily due to investment in products specifically for UK Government customers which remain under development. Product release is expected in Q1 2027. Development costs capitalised on all other products are at least offset by their amortisation charges. The net intangible asset balance is expected to decrease from next financial year.
In H1 2026 the Group negotiated loan finance for the specific purpose of developing product for the French government contract expected to be awarded in coming months.
Cash flow
As at 31 July 2025, the Group had net borrowings of £2.5m. This represents an increase in the net debt position of £1.5m compared to 31 January 2025, and £1.7m on 31 July 2024. The main components of the cash flows in the first half of the year are attributable to the following movements:
· Cash generated from operations increased to £1.5m in the first half of 2025, up from £1.3m in the same period last year. This was primarily driven by similar EBITDA and favourable working capital movements due to the timing of payments and receipts.
· Capitalised expenditure on software, product development, and intellectual property amounted to £2.2m for the first half of the year compared to £2.1m for the same period last year. We expect lower capitalised R&D spending in the current year due to in year restructuring.
· Expenditure on PPE, lease payments and net tax payments remained broadly consistent with last year at approximately £0.5m while interest paid increased to £0.3m due to the drawn RCF.
· In H1 FY25, a contract with a major European customer necessitated the deposit of £0.4m in escrow. This amount is scheduled to be repaid to us in instalments throughout the contract term.
The first six months are typically cash-consumptive due to the timing of renewals and investment in research and development. This year, the first half benefited from cash collected ahead of expected payment dates, resulting in better-than-expected cash performance and an improvement compared to the same period last year. The high weighting of renewals in the fourth quarter is expected to support higher gross cash inflows in H2, consistent with previous years.
|
Free cash flow |
|
H1 2026 |
H1 2025 |
|
|
|
£'000 |
£'000 |
|
Cash generated from operations |
|
1,500 |
1,259 |
|
Expenditure on software, product development and intellectual property capitalised |
|
(2,191) |
(2,096) |
|
Lease payments |
|
(331) |
(391) |
|
Purchase of property, plant and equipment |
|
(80) |
(133) |
|
Net interest paid |
|
(312) |
(228) |
|
Net tax paid |
|
(49) |
(34) |
|
Bank guarantee |
|
- |
(385) |
|
Free cash flow |
|
(1,463) |
(2,008) |
Financing
The Group maintains a £5.4m Revolving Credit Facility to support its working capital needs. The secured facility, renewed in May 2024, has a three-year commitment period and is priced on competitive terms. As at 31 July 2025, £4.5m was drawn from the facility.
In addition to the Group's Revolving Credit Facility, €1.5 million of French government-backed loans were drawn during the period. These loans are specifically allocated to support development activities required under the large contract with the French government. The loans carry competitive interest rates and are repayable over a five-year term.
|
Condensed consolidated statement of comprehensive income Six months ended 31 July 2025 |
||||
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
Six months ended 31 July 2025 |
Six months ended 31 July 2024 |
Year ended 31 January 2025 |
|
|
|
|
|
|
|
|
Note |
£'000 |
£'000 |
£'000 |
|
Revenue |
4 |
17,653 |
16,246 |
33,383 |
|
Cost of sales |
|
(8,847) |
(7,759) |
(14,842) |
|
Gross profit |
|
8,806 |
8,487 |
18,541 |
|
Administrative expenses |
|
(8,808) |
(8,421) |
(17,669) |
|
|
|
(2) |
66 |
872 |
|
Adjusted EBITDA |
3 |
2,102 |
2,009 |
5,616 |
|
Less: depreciation |
|
(66) |
(71) |
(149) |
|
Less: depreciation on right of use asset |
|
(294) |
(342) |
(743) |
|
Less: amortisation and impairment of intangible assets |
8 |
(1,532) |
(1,484) |
(3,305) |
|
Less: share-based payment charge |
|
(24) |
(46) |
(11) |
|
Less: strategic, integration and other non-recurring items |
|
(188) |
- |
(536) |
|
Operating profit/(loss) |
|
(2) |
66 |
872 |
|
Finance income |
|
7 |
9 |
22 |
|
Finance cost |
|
(319) |
(237) |
(677) |
|
Net finance cost |
|
(312) |
(228) |
(655) |
|
(Loss)/profit before tax |
|
(314) |
(162) |
217 |
|
Income tax charge |
5 |
(20) |
(34) |
(50) |
|
(Loss)/profit for the period |
|
(334) |
(196) |
167 |
|
Other comprehensive income |
|
|
|
|
|
Items that may subsequently be reclassified to profit or loss: |
|
- |
- |
(2) |
|
Actuarial gains/(losses) arising on defined benefit pension, net of tax |
|
- |
- |
- |
|
Exchange differences on translating foreign operations |
|
215 |
(70) |
(128) |
|
Other comprehensive (loss)/income for the period, net of tax |
|
215 |
(70) |
(130) |
|
Total comprehensive (loss)/gain for the period attributable to the equity shareholders of the Parent |
|
(119) |
(266) |
37 |
|
|
||||
(Loss)/profit per ordinary share from continuing operations attributable to the equity shareholders of the Parent during the period (expressed in pence per ordinary share):
|
|
|
Unaudited Six months ended 31 July 2025 |
Unaudited Six months ended 31 July 2024 |
Audited Year ended 31 January 2025 |
|
|
|
|
|
|
|
Basic (loss)/earnings per share |
6 |
(0.3) |
(0.2) |
0.2 |
|
|
|
|
|
|
|
Diluted (loss)/earnings per share |
6 |
(0.3) |
(0.2) |
0.1 |
|
Condensed consolidated statement of financial position As at 31 July 2025 |
||||
|
|
|
Unaudited |
Audited |
Unaudited |
|
|
|
As at 31 July 2025 |
As at 31 January 2025 |
As at 31 July 2024 |
|
|
Note |
£'000 |
£'000 |
£'000 |
|
Assets |
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Intangible assets including goodwill |
8 |
22,458 |
21,512 |
20,451 |
|
Property, plant and equipment |
|
277 |
266 |
257 |
|
Right-of-use assets |
|
1,164 |
1,190 |
1,003 |
|
Restricted cash |
|
460 |
460 |
460 |
|
Total non-current assets |
|
24,359 |
23,428 |
22,171 |
|
Current assets |
|
|
|
|
|
Trade and other receivables |
9 |
15,106 |
14,386 |
12,556 |
|
Cash and cash equivalents |
10 |
3,733 |
3,627 |
3,111 |
|
Total current assets |
|
18,839 |
18,013 |
15,667 |
|
Total assets |
|
43,198 |
41,441 |
37,838 |
|
Liabilities |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Bank borrowings |
10 |
(380) |
(369) |
(319) |
|
Trade and other payables |
11 |
(15,319) |
(14,956) |
(12,992) |
|
Current income tax payable |
|
(124) |
(171) |
(25) |
|
Lease liabilities |
|
(497) |
(422) |
(363) |
|
Provisions |
|
(316) |
(316) |
- |
|
Total current liabilities |
|
(16,636) |
(16,234) |
(13,699) |
|
Non-current liabilities |
|
|
|
|
|
Bank borrowings |
10 |
(5,876) |
(4,273) |
(3,647) |
|
Lease liabilities |
|
(791) |
(911) |
(737) |
|
Provisions |
|
- |
(75) |
- |
|
Defined benefit pension obligation |
|
(1,266) |
(1,226) |
(1,238) |
|
Deferred tax |
|
(236) |
(241) |
(337) |
|
Total non-current liabilities |
|
(8,169) |
(6,726) |
(5,959) |
|
Total liabilities |
|
(24,805) |
(22,960) |
(19,658) |
|
Net assets |
|
18,393 |
18,481 |
18,180 |
|
|
|
|
|
|
|
Share capital and reserves |
|
|
|
|
|
Share capital |
12 |
20,194 |
20,191 |
20,179 |
|
Share premium account |
|
30,601 |
30,597 |
30,577 |
|
Own shares held |
|
(14) |
(14) |
(14) |
|
Equity-settled employee benefits reserve |
|
4,124 |
4,100 |
4,135 |
|
Merger reserve |
|
16,465 |
16,465 |
16,465 |
|
Reverse acquisition reserve |
|
(11,584) |
(11,584) |
(11,584) |
|
Currency translation reserve |
|
393 |
178 |
235 |
|
Accumulated losses |
|
(41,309) |
(41,975) |
(41,336) |
|
Purchase of non-controlling interest reserves |
|
(477) |
(477) |
(477) |
|
Equity attributable to shareholders of the Parent company |
|
18,393 |
18,481 |
18,180 |
|
Total equity |
|
18,393 |
18,481 |
18,180 |
|
|
|
|
|
|
|
Condensed consolidated statement of changes in equity Period ended 31 July 2025 |
|
|||||||||
|
£'000 |
Share capital |
Share premium account |
Own shares held |
Equity-settled employee benefits reserve |
Merger reserve |
Reverse acquisition reserve |
Currency translation reserve |
Purchase of non-controlling interest reserve |
Accumulated losses |
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 January 2024 (Audited) |
20,155 |
30,508 |
(14) |
4,089 |
16,465 |
(11,584) |
305 |
(477) |
(41,140) |
18,307 |
|
Comprehensive income/(loss) |
|
|
|
|
|
|
|
|
|
|
|
Profit for the year |
- |
- |
- |
- |
- |
- |
- |
- |
167 |
167 |
|
Other comprehensive income/(loss) |
|
|
|
|
|
|
|
|
|
|
|
Actuarial gains arising on defined benefit pension |
- |
- |
- |
- |
- |
- |
- |
- |
(2) |
(2) |
|
Exchange differences on translating foreign operations |
- |
- |
- |
- |
- |
- |
(127) |
- |
- |
(127) |
|
Total other comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
(127) |
- |
(2) |
(129) |
|
Total comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
(127) |
- |
165 |
38 |
|
Transactions with owners recognised directly in equity |
|
|
|
|
|
|
|
|
|
|
|
Recognition of share-based payments |
- |
- |
- |
11 |
- |
- |
- |
- |
- |
11 |
|
Issue of shares held in treasury (including exercise of share options) |
36 |
89 |
- |
- |
- |
- |
- |
- |
- |
125 |
|
|
36 |
89 |
- |
11 |
- |
- |
- |
- |
- |
136 |
|
Balance at 31 January 2025 (Audited) |
20,191 |
30,597 |
(14) |
4,100 |
16,465 |
(11,584) |
178 |
(477) |
(40,975) |
18,481 |
|
Comprehensive income/(loss) |
|
|
|
|
|
|
|
|
|
|
|
Profit for the period |
- |
- |
- |
- |
- |
- |
- |
- |
(334) |
(334) |
|
Other comprehensive income |
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
- |
- |
- |
- |
- |
- |
215 |
- |
- |
215 |
|
Total other comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
215 |
- |
(334) |
(119) |
|
Total comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
215 |
- |
(334) |
(119) |
|
Transactions with owners recognised directly in equity |
|
|
|
|
|
|
|
|
|
|
|
Recognition of share-based payments |
- |
- |
- |
24 |
- |
- |
- |
- |
- |
24 |
|
Issue of share capital |
3 |
4 |
|
|
|
|
|
|
|
7 |
|
|
3 |
4 |
- |
24 |
- |
- |
- |
- |
- |
31 |
|
Balance at 31 July 2025 (Unaudited) |
20,194 |
30,601 |
(14) |
4,124 |
16,465 |
(11,584) |
393 |
(477) |
(41,309) |
18,393 |
|
£'000 |
Share capital |
Share premium account |
Own shares held |
Equity-settled employee benefits reserve |
Merger reserve |
Reverse acquisition reserve |
Currency translation reserve |
Purchase of non-controlling interest reserve |
Accumulated losses |
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 January 2024 (Audited) |
20,155 |
30,508 |
(14) |
4,089 |
16,465 |
(11,584) |
305 |
(477) |
(41,140) |
18,307 |
|
Comprehensive loss |
|
|
|
|
|
|
|
|
|
|
|
Profit for the period |
- |
- |
- |
- |
- |
- |
- |
- |
(196) |
(196) |
|
Other comprehensive (loss)/income |
|
|
|
|
|
|
|
|
|
|
|
Exchange differences on translating foreign operations |
- |
- |
- |
- |
- |
- |
(70) |
- |
- |
(70) |
|
Total other comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
(70) |
- |
(196) |
(269) |
|
Total comprehensive (loss)/income |
- |
- |
- |
- |
- |
- |
(70) |
- |
(196) |
(269) |
|
Transactions with owners recognised directly in equity |
|
|
|
|
|
|
|
|
|
|
|
Recognition of share-based payments |
- |
- |
- |
46 |
- |
- |
- |
- |
- |
46 |
|
Issue of share capital |
24 |
69 |
|
|
|
|
|
|
|
93 |
|
|
24 |
69 |
- |
46 |
- |
- |
(70) |
- |
(196) |
(130) |
|
Balance at 31 July 2024 (Unaudited) |
20,179 |
30,577 |
(14) |
4,135 |
16,465 |
(11,584) |
235 |
(477) |
(41,336) |
18,180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed consolidated statement of cash flows Period ended 31 July 2025 |
||||
|
|
|
Unaudited
|
Unaudited
|
Audited
|
|
|
|
Six months ended 31 July 2025 |
Six months ended 31 July 2024 |
Year ended 31 January 2025 |
|
|
Note |
£'000 |
£'000 |
£'000 |
|
Cash flows from operating activities |
|
|
|
|
|
Cash generated from operations |
10 |
1,500 |
1,259 |
4,942 |
|
Interest received |
|
7 |
9 |
22 |
|
Interest paid |
|
(319) |
(237) |
(677) |
|
Tax paid |
|
(49) |
(34) |
(218) |
|
Tax received |
|
- |
- |
- |
|
Deposit |
|
- |
(385) |
75 |
|
Net cash from operating activities |
|
1,139 |
612 |
4,144 |
|
Cash flows from investing activities |
|
|
|
|
|
Purchase of property, plant and equipment |
|
(80) |
(133) |
(216) |
|
Expenditure on product development and intellectual property capitalised |
|
(2,191) |
(2,096) |
(4,839) |
|
Performance deposit |
|
- |
- |
(460) |
|
Net cash used in investing activities |
|
(2,271) |
(2,230) |
(5,515) |
|
Cash flows from financing activities |
|
|
|
|
|
Proceeds from loans and borrowings |
|
1,796 |
1,120 |
2,120 |
|
Repayment of loans and borrowings |
|
(202) |
(318) |
(633) |
|
Repayment of lease obligations |
|
(331) |
(391) |
(843) |
|
Net proceeds from share issue |
|
7 |
93 |
125 |
|
Net cash used in financing activities |
|
1,270 |
504 |
769 |
|
Net increase / (decrease) in cash and cash equivalents |
|
138 |
(1,114) |
(602) |
|
Cash and cash equivalents at start of period |
|
3,627 |
4,260 |
4,260 |
|
Effects of foreign exchange on cash and cash equivalents |
|
(32) |
(35) |
(31) |
|
Cash and cash equivalents at end of period |
10 |
3,733 |
3,111 |
3,627 |
|
|
|
|
|
|
|
|
||||
Notes to the Interim Financial Statements
1. Principal activity
1Spatial plc is a public limited company which is listed on the AIM London Stock Exchange and is incorporated and domiciled in the
The principal activity of the Group is the development and sale of software along with related consultancy and support.
2. Basis of preparation
This condensed consolidated interim financial report for the half-year reporting period ended 31 July 2025 has been prepared in accordance with
The accounting policies adopted in the preparation of the interim financial statements are consistent with those followed in the preparation of the Group's consolidated financial statements as at and for the year ended 31 January 2025.The Group has not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.
Several amendments and interpretations apply for the first time in 2025, but do not have a material impact on the interim financial statements of the Group.
The financial information for the six months ended 31 July 2025 and 31 July 2024 is neither audited nor reviewed and does not constitute statutory financial statements within the meaning of section 434(3) of the Companies Act 2006 for 1Spatial plc or for any of the entities comprising the 1Spatial Group. Statutory financial statements for the preceding financial year ended 31 January 2025 were filed with the Registrar and included an unqualified auditors' report.
After making enquiries, the Directors have a reasonable expectation that the Company and the Group have adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the half-yearly condensed consolidated financial statements.
These interim financial statements were authorised for issue by the Company's Board of Directors on 12 October 2025.
3. Alternative Performance Measures ('APMs')
The Group uses certain Alternative Performance Measures to enable the users of the Group's financial statements to understand and evaluate the performance of the Group consistently over different reporting periods. APMs are non-GAAP company specific measures. As these are non-GAAP measures, they should not be considered as replacements for IFRS measures. The Group's definition of non-GAAP measures may not be comparable to other similarly titled measures reported by other companies. A description of the measures set out above is included below with a reconciliation to the closest GAAP measure included in the notes to the consolidated condensed interim financial report.
|
APM |
Explanation of APM |
|
Recurring Revenue (s)
|
Recurring Revenue is the value of committed recurring contracts for term licences and support & maintenance recorded in the year. |
|
Annualised Recurring Revenue ("ARR") |
Annualised Recurring Revenue ("ARR") is the annualised value at the year-end of committed recurring contracts for term licences and support & maintenance. |
|
Adjusted EBITDA
|
Adjusted EBITDA is a company-specific measure which is calculated as operating profit/(loss) before depreciation (including right of use asset depreciation), amortisation and impairment of intangible assets, share-based payment charge and strategic, integration, and other non-recurring items. |
|
Operating cashflow |
Operating cashflow is a company-specific measure which is calculated as cash generated from operations excluding cash flow on strategic, integration and other non-recurring items. |
|
Free cashflow |
Free cash flow is defined as net increase/(decrease) in cash for the year before cash flows from the acquisition of subsidiaries, cash flows from new borrowings and repayments of borrowings and cash flow from new share issue. But excludes lease liabilities. |
|
Net cash/(borrowings) |
Net cash/(borrowings) is gross cash less bank borrowings. |
|
Recurring Revenue |
H1 2026 |
H1 2025 |
FY2025 |
|
Total Revenue |
17,653 |
16,246 |
33,383 |
|
Adjustments: |
|
|
|
|
Services |
(6,810) |
(6,851) |
(11,792) |
|
Perpetual Licences - own |
(26) |
(51) |
(103) |
|
Perpetual Licences - third party |
(121) |
(436) |
(759) |
|
Recurring Revenue |
10,696 |
8,908 |
20,729 |
|
|
|
|
|
|
Annualised Recurring Revenue |
H1 2026 |
H1 2025 |
FY2025 |
|
Recurring Revenue |
10,696 |
8,908 |
20,729 |
|
Adjustments: |
|
|
|
|
Timing differences on Net New Revenue in period |
9,175 |
9,014 |
(1,026) |
|
Annualised Recurring Revenue |
19,871 |
17,922 |
19,703 |
|
|
|
|
|
|
Adjusted EBITDA |
H1 2026 |
H1 2025 |
FY2025 |
|
(Loss)/profit before tax |
(314) |
(162) |
217 |
|
Adjustments: |
|
|
|
|
Depreciation |
360 |
413 |
892 |
|
Amortisation and impairment of intangible assets |
1,532 |
1,484 |
3,305 |
|
Share-based payment charge |
24 |
46 |
11 |
|
Strategic, integration and other one-off items |
188 |
- |
536 |
|
Net finance cost |
312 |
228 |
655 |
|
Adjusted EBITDA |
2,102 |
2,009 |
5,616 |
|
|
|
|
|
|
Operating Cashflow |
H1 2026 |
H1 2025 |
FY2025 |
|
Cash generated from operations |
1,500 |
1,259 |
4,942 |
|
Adjustments: |
|
|
|
|
Cash flow on strategic, integration and other non-recurring items |
212 |
- |
123 |
|
Cash generated from operations before strategic, integration and other non-recurring items |
1,712 |
1,259 |
5,065 |
|
|
|
|
|
|
Free cash flow |
H1 2026 |
H1 2025 |
FY2025 |
|
Cash generated from operations before strategic, integration and other non-recurring items |
1,712 |
1,259 |
4,942 |
|
Adjustments: |
|
|
|
|
Net interest paid |
(312) |
(228) |
(655) |
|
Net tax (paid)/received |
(49) |
(34) |
(218) |
|
Deposits |
|
|
(385) |
|
Expenditure on product development and intellectual property capitalised |
(2,191) |
(2,096) |
(4,839) |
|
Purchase of property, plant and equipment |
(80) |
(133) |
(216) |
|
Lease payments |
(331) |
(391) |
(843) |
|
Free cash flow before strategic, integration and other non-recurring items |
(1,251) |
(1,623) |
(2,214) |
|
Cash flow on strategic, integration and other non-recurring items |
(212) |
- |
(123) |
|
Free cash flow |
(1,463) |
(1,623) |
(2,337) |
|
|
|
|
|
|
|
H1 2026 |
H1 2025 |
FY2025 |
|
Cash and cash equivalents |
3,733 |
3,111 |
3,627 |
|
Adjustments: |
|
|
|
|
Bank Borrowings - current |
(380) |
(319) |
(369) |
|
Bank Borrowings - non-current |
(5,876) |
(3,647) |
(4,273) |
|
Net Borrowings |
(2,523) |
(855) |
(1,015) |
|
|
|
|
|
4. Revenue
The following table provides an analysis of the Group's revenue by type:
|
Revenue by type |
|
|
|
|
|
H1 2026 |
H1 2025 |
|
|
|
£000 |
£000 |
|
|
SaaS Solutions |
0.76 |
0.20 |
280% |
|
Term licences - own |
2.55 |
2.94 |
(13%) |
|
Term licences - third party |
3.14 |
1.15 |
173% |
|
SaaS and Term licences - total |
6.45 |
4.29 |
50% |
|
Support & maintenance |
4.25 |
4.62 |
(8%) |
|
Recurring revenue |
10.70 |
8.91 |
20% |
|
Services |
6.81 |
6.85 |
(1%) |
|
Perpetual licences - own |
0.03 |
0.05 |
(40%) |
|
Perpetual licences - third party |
0.11 |
0.43 |
(72%) |
|
Perpetual licences - total |
0.14 |
0.48 |
(69%) |
|
Total revenue |
17.65 |
16.24 |
9% |
|
Percentage of recurring revenue |
61% |
55% |
|
5. Taxation
The tax charge on the result for the six months ended 31 July 2025 is based on the estimated tax rates in the jurisdictions in which the Group operates for the year ending 31 January 2026.
6. (Loss)/earnings per share
Basic (loss)/earnings per share is calculated by dividing the (loss)/profit attributable to equity holders of the Company by the weighted average number of ordinary shares in issue during the period.
|
|
Unaudited |
Unaudited |
Audited |
|
|
|
Six months ended 31 July 2025 |
Six months ended 31 July 2024 |
Year ended 31 January 2025 |
|
|
|
£'000 |
£'000 |
£'000 |
|
|
(Loss)/profit attributable to equity holders of the Parent |
(334) |
(196) |
167 |
|
|
|
||||
|
|
|
|
|
|
|
|
Number |
Number |
Number |
|
|
|
000s |
000s |
000s |
|
|
Ordinary shares with voting rights |
111,427 |
110,889 |
111,063 |
|
|
Basic weighted average number of ordinary shares |
111,351 |
110,859 |
111,063 |
|
|
Impact of share options/LTIPs |
2,765 |
4,569 |
3,848 |
|
|
Diluted weighted average number of ordinary shares |
114,116 |
115,459 |
114,911 |
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
Six months ended 31 July 2025 |
Six months ended 31 July 2024 |
Year ended 31 January 2025 |
|
|
Pence |
Pence |
Pence |
|
Basic (loss)/earnings per share |
(0.3) |
(0.2) |
0.2 |
|
Diluted (loss)/earnings per share |
(0.3) |
(0.2) |
0.1 |
There is no material difference between basic earnings per share and diluted earnings per share.
7. Dividends
No dividend is proposed for the six months ended 31 July 2025 (31 January 2025: nil; 31 July 2024: nil).
8. Intangible assets including goodwill
|
|
Goodwill |
Brands |
Customers and related contracts |
Software |
Development costs |
Intellectual property |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Cost |
|
|
|
|
|
|
|
|
At 1 February 2025 |
17,407 |
450 |
4,560 |
6,649 |
35,198 |
83 |
64,347 |
|
Additions |
- |
- |
- |
- |
2,191 |
- |
2,191 |
|
Effect of foreign exchange |
(61) |
7 |
112 |
110 |
381 |
- |
549 |
|
At 31 July 2025 |
17,346 |
457 |
4,672 |
6,759 |
37,770 |
83 |
67,087 |
|
Accumulated impairment and amortisation |
|
|
|
|
|
|
|
|
At 1 February 2025 |
11,338 |
358 |
4,085 |
5,640 |
21,381 |
32 |
42,834 |
|
Amortisation |
- |
11 |
65 |
112 |
1,342 |
2 |
1,532 |
|
Effect of foreign exchange |
44 |
4 |
98 |
80 |
277 |
- |
503 |
|
At 31 July 2025 |
11,382 |
373 |
4,248 |
5,832 |
23,000 |
34 |
44,869 |
|
Net book amount at 31 July 2025 |
5,964 |
84 |
424 |
927 |
14,770 |
49 |
22,218 |
|
|
Goodwill |
Brands |
Customers and related contracts |
Software |
Development costs |
Intellectual property |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Cost |
|
|
|
|
|
|
|
|
At 1 February 2024 |
17,449 |
455 |
4,630 |
6,695 |
30,508 |
83 |
59,820 |
|
Additions |
- |
- |
- |
23 |
2,096 |
- |
2,119 |
|
Effect of foreign exchange |
(91) |
(3) |
(44) |
(43) |
(175) |
- |
(356) |
|
At 31 July 2024 |
17,358 |
452 |
4,586 |
6,675 |
32,429 |
83 |
61,583 |
|
Accumulated impairment and amortisation |
|
|
|
|
|
|
|
|
At 1 February 2024 |
11,409 |
338 |
3,997 |
5,465 |
18,631 |
29 |
39,869 |
|
Amortisation |
- |
11 |
74 |
114 |
1,283 |
2 |
1,484 |
|
Effect of foreign exchange |
(44) |
(1) |
(36) |
(30) |
(110) |
- |
(221) |
|
At 31 July 2024 |
11,365 |
348 |
4,035 |
5,549 |
19,804 |
31 |
41,132 |
|
Net book amount at 31 July 2024 |
5,993 |
104 |
551 |
1,126 |
12,625 |
52 |
20,451 |
|
|
Goodwill |
Brands |
Customers and related contracts |
Software |
Development costs |
Intellectual property |
Total |
|
|
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
|
Cost |
|
|
|
|
|
|
|
|
At 1 February 2024 |
17,449 |
455 |
4,630 |
6,695 |
30,508 |
83 |
59,820 |
|
Additions |
- |
- |
- |
- |
4,839 |
- |
4,839 |
|
Effect of foreign exchange |
(42) |
(5) |
(70) |
(46) |
(149) |
- |
(312) |
|
At 31 January 2025 |
17,407 |
450 |
4,560 |
6,649 |
35,198 |
83 |
64,347 |
|
|
|
|
|
|
|
|
|
|
Accumulated impairment and amortisation |
|
|
|
|
|
|
|
|
At 1 February 2024 |
11,409 |
338 |
3,997 |
5,465 |
18,631 |
29 |
39,869 |
|
Amortisation |
- |
22 |
147 |
223 |
2,620 |
3 |
3,015 |
|
Effect of foreign exchange |
(71) |
(2) |
(59) |
(48) |
(160) |
- |
(340) |
|
At 31 January 2025 |
11,338 |
358 |
4,085 |
5,640 |
21,381 |
32 |
42,834 |
|
Net book amount at 31 January 2025 |
6,069 |
92 |
475 |
1,009 |
13,817 |
51 |
21,513 |
|
Net book amount at 31 January 2024 |
6,040 |
117 |
633 |
1,230 |
11,877 |
54 |
19,951 |
9. Trade and other receivables
|
|
As at 31 July 2025 |
As at 31 January 2025 |
As at 31 July 2024 |
|
Current |
£'000 |
£'000 |
£'000 |
|
Trade receivables |
3,669 |
4,708 |
3,892 |
|
Less: provision for impairment of trade receivables |
(16) |
(16) |
(19) |
|
|
3,653 |
4,692 |
3,873 |
|
Other receivables |
1,127 |
1,205 |
1,403 |
|
Prepayments and accrued income |
10,326 |
8,489 |
7,280 |
|
|
15,106 |
14,386 |
12,556 |
|
10. Notes to the condensed consolidated statement of cash flows |
|||
|
a) Cash used in operations |
|
|
|
|
|
Unaudited |
Unaudited |
Audited |
|
|
Six months ended 31 July 2025 |
Six months ended 31 July 2024 |
Year ended 31 January 2025 |
|
|
£'000 |
£'000 |
£'000 |
|
|
|
|
|
|
Profit/(loss) before tax |
(313) |
(162) |
217 |
|
Adjustments for: |
|
|
|
|
Net finance cost |
312 |
228 |
655 |
|
Depreciation |
360 |
413 |
892 |
|
Amortisation of acquired intangibles |
182 |
192 |
395 |
|
Amortisation and impairment of development costs |
1,350 |
1,292 |
2,910 |
|
Share-based payment charge |
24 |
46 |
11 |
|
Decrease/(increase) in trade and other receivables |
(566) |
98 |
(1,658) |
|
(Decrease)/increase in trade and other payables |
151 |
(882) |
1,536 |
|
Increase/(decrease) in defined benefit pension obligation |
- |
34 |
(16) |
|
Net foreign exchange movement |
- |
- |
- |
|
Cash from operations |
1,500 |
1,259 |
4,942 |
|
|
|||
|
b) Reconciliation of net cash flow to movement in net funds |
|||
|
|
Unaudited |
Unaudited |
Audited |
|
|
As at 31 July 2025 |
As at 31 July 2024 |
As at 31 January 2025 |
|
|
£'000 |
£'000 |
£'000 |
|
Increase/ (decrease) in cash in the period |
138 |
(1,113) |
(602) |
|
Changes resulting from cash flows |
138 |
(1,113) |
(602) |
|
|
|
|
|
|
Net cash inflow in respect of new borrowings |
(1,796) |
(1,120) |
(2,120) |
|
Net cash outflow in respect of borrowings repaid |
202 |
318 |
633 |
|
Effect of foreign exchange |
(52) |
(19) |
(5) |
|
Change in net funds |
(1,508) |
(1,934) |
(2,094) |
|
Net funds at beginning of period |
(1,015) |
1,079 |
1,079 |
|
Net funds at end of period |
(2,523) |
(855) |
(1,015) |
|
|
|
|
|
|
Analysis of net funds |
|
|
|
|
Cash and cash equivalents classified as: |
|
|
|
|
Current assets |
3,733 |
3,111 |
3,627 |
|
Bank and other loans |
(6,256) |
(3,966) |
(4,642) |
|
Net funds at end of period |
(2,523) |
(855) |
(1,015) |
Net funds are defined as cash and cash equivalents net of bank loans.
11. Trade and other payables
|
|
As at 31 July 2025 |
As at 31 January 2025 |
As at 31 July 2024 |
|
Current |
£'000 |
£'000 |
£'000 |
|
Trade payables |
4,978 |
4,627 |
3,392 |
|
Other taxation and social security |
3,494 |
3,269 |
2,846 |
|
Other payables |
275 |
211 |
387 |
|
Accrued liabilities |
1,487 |
907 |
1,087 |
|
Deferred income |
5,085 |
5,942 |
5,279 |
|
|
15,319 |
14,956 |
12,992 |
12. Share capital
|
|
As at 31 July 2025 |
As at 31 January 2025 |
As at 31 July 2024 |
|
|
£'000 |
£'000 |
£'000 |
|
Allotted, called up and fully paid |
|
|
|
|
111,427,204 (FY 2025: 111,317,829 H1 FY 2025: 111,197,390) ordinary shares of 10p each |
11,126 |
11,123 |
11,211 |
|
226,699,878 (FY 2025 and H1 FY 2025: 226,699,878) deferred shares of 4p each |
9,068 |
9,068 |
9,068 |
|
|
20,194 |
20,191 |
20,179 |
There are 111,427,204 ordinary shares of 10p in issue, of which 15,399 ordinary shares are held in treasury. Consequently, the total number of voting rights is 111,411,805.
The deferred shares of 4p each do not carry voting rights or a right to receive a dividend. Accordingly, the deferred shares will have no economic value.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE